Chapter 48: Hematologic & Immunologic Disorders in Children

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement, not replace the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome back to the Deep Dive, where we take complex clinical chapters and synthesize them into the crucial, actionable knowledge you need to walk onto the unit and practice confidently.

Today, we are undertaking an absolutely critical deep dive into pediatric hematological and immunological conditions.

In maternal child nursing, especially here in the Canadian healthcare context,

recognizing these disorders early is just foundational.

We're talking about everything from common, easily treatable anemias to life -threatening issues like leukemia or severe immunodeficiencies like SEID.

And the nurse is often that critical link, right?

For early detection, meticulous medication administration and just huge family support.

That's the mission.

We have to distill the core path of physiology, key assessments, lab interpretations, especially the complete blood cell count or CBC and the essential step -by -step nursing interventions.

And we really have to view this material through the lens of vulnerability.

I'm thinking about our Canadian indigenous infants and children who, you know, due to systemic issues like poverty and food insecurity, face these disproportionately high rates of nutritional disorders like iron deficiency anemia.

Yes, or even new immigrant families who may carry genetic risks for conditions like thalassemia that require intensive lifelong care.

Early recognition is everything and it really starts with you.

You are often the very first person to suspect a hematological or immune problem through careful history and a physical exam.

So what are you looking for in that history?

Is the child persistently lacking energy?

Are they poorly nourished?

Are they getting frequent really severe infections or are they bruising uncontrollably?

Those are the crucial clues.

Things like pallor, patechia, bruising, or just extreme fatigue on the physical exam can be massive red flags.

But when we move from just suspicion to diagnosis, the single most common and valuable piece of hard data we rely on is the complete blood cell count, the CBC.

Exactly.

The CBC gives us this incredible comprehensive snapshot of all three major components of blood.

Red cells, white cells, and platelets.

And as you're scanning that report, there is one term that signals an immediate acute defense response.

That's the shift to the left.

Yes.

Okay, let's unpack this concept right away.

A shift to the left sounds like something you see when the bone marrow is, what, stressed, hyperfunctioning.

What's actually being shifted?

It refers to the presence of an increased number of immature neutrophils, specifically the band cells in the peripheral blood circulation.

Okay.

Normally, bands are stored in the bone marrow until they mature into what we call segmented neutrophils.

Right, the mature ones.

When the marrow is suddenly working over time hyperfunctioning to fight a massive, usually bacterial infection,

it just pushes out these immature cells.

So it's the body's reserves being called up to the front lines.

Precisely.

It's an abnormal CBC term that tells us the body is fighting a vigorous, acute battle.

It's a really serious finding that requires rapid intervention.

So the CBC isn't just some routine test.

It's a clinical blueprint.

To guide our decision -making, we need to master the components, and table 48 .1 in the text lays it all out.

We'll start with the three foundational metrics for red blood cells.

The RBC count, hemoglobin, or HgB, and hematocrit, Hgt.

And HgB and HgD are really how we quantify the blood's true purpose, which is carrying oxygen.

The HgB is the actual protein responsible for transport, and Hgt is the percentage of the packed cell volume relative to the total blood volume.

So when these are below the age and gender -specific norms, we're looking at a reduction in oxygen carrying capacity.

That's the definition of anemia.

Knowing the patient is anemic is step one, but step two is classifying what kind of anemia it is.

And that requires us to dive into the red blood cell indices, specifically the mean corpuscular volume, MCV, and the mean corpuscular hemoglobin concentration, MCHC.

Why are these kind of arcane sounding acronyms so critical for the nurse?

They allow us to classify the anemia by morphology, what the cells actually look like.

So size and shape.

Exactly.

The MCV tells us the average size of the cell.

If it's low, the cell is microcytic, meaning small.

If it's high, it's macrocytic or large.

And MCHC.

The MCHC tells us the concentration of hemoglobin inside, which dictates color.

If it's low, the cell is hypochromic.

It's pale.

So if the MCV is low and the MCHC is low microcytic, hypochromic, that gives us an immediate, strong index of suspicion.

Exactly.

As detailed in box 48 .1, small pale cells immediately point you toward iron deficiency anemia or maybe thalassemia.

And the opposite.

Conversely, if the MCV is high, so microcytic, you're looking at nutritional deficiencies like B12 or folate.

These indices dictate the diagnostic pathway and the initial treatment approach before you even get definitive testing results.

Wow, so they really tell you why the oxygen transport is failing.

That's the key.

Next up, we have the reticulocyte count.

I always think of this as the Bone Marrows production report card.

It tells us how the marrow is responding to the anemia.

That analogy holds up perfectly.

The reticulocyte count measures the percentage of immature RBCs being produced and released into circulation.

So if you see a decreased count in an anemic child, what does that signal?

It tells you the bone marrow is depressed or failing.

It's just not capable of producing enough cells.

This points you toward something like a plastic anemia or maybe bone marrow invasion by leukemia.

But what if the count is increased?

An increased count means the marrow is hyperactive.

It's pushing out cells in response to a stimulus.

We call it erythrogenesis.

And that stimulus is usually?

It's usually rapid destruction, like in sickle cell anemia or thalassemia or maybe acute blood loss.

It helps you differentiate between a production problem and a destruction problem.

Okay, that's a really clear distinction.

Now, shifting to white blood cells, the total count gives us the overall infection or inflammation status, but the real depth comes in the differential.

Right, the differential quantifies the five major types of white blood cells.

We pay very close attention to the neutrophils, which are our primary defense against bacteria.

And the most vital calculation derived from this differential is the absolute neutrophil count or ANC.

The ANC is the number that matters most in oncology nursing, period.

Why is it so critical?

It is the absolute measure of the body's ability to defend against bacterial infection.

If the ANC is profoundly low, typically less than 0 .5 times 10 to the nine per liter, the child is severely neutropenic.

And that means?

It means they require intensive protective isolation regardless of what the overall WBC count is.

Got it.

Finally, we look at platelets.

These are the cellular fragments that initiate the clotting cascade.

Low counts, thrombocytopenia, mean a high bleeding risk.

High counts mean a clotting risk.

The CVC is truly the nurse's initial indispensable tool.

As we transition into specific anemias, let's just reinforce that anemia is the reduction of RBCs or HDB, diminishing oxygen carrying capacity.

Yes.

We must never treat it as the disease itself, but as a manifestation of an underlying problem.

Right, and as figure 48 .1 illustrates, we classify anemias by etiology.

Is it decreased production like nutritional or marrow failure, increased loss like a hemorrhage, or increased destruction like in sickle cell disease?

That classification is the key to treatment, isn't it?

It's everything.

So if we look at the consequences in figure 48 .1 and 48 .2, we see these profound systemic effects.

The classic symptoms pallor, fatigue, are obvious, but let's talk circulatory effects.

Severe anemia leads to hemodilution.

What does that mean for the heart?

It's a massive, massive stressor.

Because the blood is less viscous, peripheral resistance drops dramatically.

So the pipes are wider in a sense.

In a sense, yes.

The heart has to pump a larger volume of blood faster and with more force to maintain adequate tissue perfusion.

And that increased workload.

That increased cardiac workload and the turbulence of the diluted blood flow can create an audible heart murmur.

And frighteningly, in acute or severe chronic cases, it can precipitate congestive heart failure.

Especially during periods of stress.

Exactly, like with a high fever or exercise.

What's really remarkable, but also a challenge for assessment is the adaptability of children.

They can tolerate very low HDB levels if the onset is slow.

They compensate so well.

And that compensation means cyanosis often isn't visible, even in severe anemia, because there just isn't enough HDB to generate the deoxygenated HDB necessary to cause that blue tinge.

That adaptation is a warning sign in itself.

It is.

And chronic severe anemia also leads to visible systemic consequences, notably growth restriction and delayed sexual maturation, because adequate oxygenation is essential for all those metabolic demands.

This just makes the nurse's assessment skills so paramount.

In the diagnostic phase, the nurse's role often involves preparing the child and family for tests, which can be terrifying for them.

You have to be proactive.

Using topical anesthetics like EMLA before needle sticks to minimize trauma and always encouraging parental presence.

And we need a simple, clear script for education.

How do you explain it?

The tech suggests explaining the components clearly.

Red cells carry oxygen, white cells fight germs, platelets help you stop bleeding, and plasma is the fluid that carries all the clotting factors.

That simple explanation can empower the family and reduce a lot of fear around blood draws and transfusions.

It really can.

So once anemia is established, the primary nursing intervention focuses on decreasing tissue oxygen needs.

Yes, you have to continuously assess their activity tolerance.

We've got to minimize oxygen expenditure.

The nursing alert box in the text gives a clear list of what signs of exertion look like.

Things like tachycardia, dyspnea, excessive sweating, diaphoresis, dizziness, and in infants, difficulty sucking, or even just completing a feed.

Recognizing those signs means adjusting schedule, clustering care.

And ensuring the child is resting appropriately to prevent that dangerous cardiac strain.

Okay, let's move to the most common hematological condition worldwide.

Iron deficiency, anemia, or IDA.

It's imperative we address the Canadian context here.

The high prevalence, up to 58 % in certain Canadian indigenous infant and child populations is a profound example of health inequity.

It's tied directly to food insecurity and poverty.

This requires us to look beyond simple dietary counseling and acknowledge the systemic factors that are at play.

What are some other common risk factors?

Low birth weight, poor eating habits, and crucially, prolonged bottle feeding past toddlerhood.

Adolescence is another peak time due to rapid growth and for females, blood loss during menses.

Let's review the key path of physiology.

Fetal iron stores are usually good for six months in a full term infant.

But only two to three months in a premature infant.

And the text makes a specific note here that delaying umbilical cord clamping by one to three minutes significantly improves the infant's iron status.

That's a simple evidence -based intervention that gives the baby a much needed boost right at birth.

It really is.

And we have to understand the milk baby concept.

It sounds cute, but it's a clinically important entity.

The milk baby is an overweight infant who has been given excessive amounts of milk, typically cow's milk, to the exclusion of iron -rich solid foods.

And milk is a notoriously poor iron source.

Very poor.

Furthermore, for infants under about nine to 12 months, fresh cow's milk is discouraged because it can cause microscopic gastrointestinal blood loss or mucosal damage, which just makes the anemia worse.

So therapeutic management is pretty straightforward.

Oral iron replacement.

We use ferrous iron and we enhance its absorption with vitamin C.

Transfusions are truly reserved only for very severe cases complicated by cardiac dysfunction or active hemorrhage.

Now let's focus on the crucial nursing care and education points.

These are absolutely non -negotiable for safety and efficacy.

First rule for administering oral iron.

It has to be given between meals.

Why is that?

That's when the stomach acid is highest, which maximizes absorption.

And never with milk or milk products, which contain substances that interfere with iron binding.

That's a common error parents make, right?

Believing milk will coat the stomach.

A very common error.

And that leads directly to the next crucial teaching point,

the expected side effect.

The stools.

Exactly.

Parents must be warned that the child's stools will turn a tarry green or greenish black.

It's as normal, it's harmless, and it actually serves as a sign of adherence.

So if they report no change, the nurse has to suspect improper administration or maybe non -adherence.

That's your cue to investigate.

And for liquid iron, which is acidic and stains teeth.

Instruct them to use a straw or dropper placed toward the back of the mouth, followed immediately by water or brushing to minimize that discoloration.

And finally, the critical safety alert.

Iron is a highly toxic substance in excess.

Accidental overdose is a major risk for young children.

Parents must be explicitly instructed to limit the supply to no more than a one month quantity and store it securely away from all children.

We're shifting gears entirely now, from a simple nutritional deficit to a severe chronic genetic structural defect, sickle cell anemia or SCA.

Mm -hmm, this is a hemoglobinopathy where the normal adult hemoglobin, HGBA, is replaced by the abnormal HGBS.

It's the homozygous form, HGBSS, inherited via an autosomal recessive pattern.

But the onset is delayed, why is that?

Because fetal hemoglobin, HGBF, is protective.

It often lasts until the second half of the first year of life.

Once those HGBF levels drop, the disease manifests, often violently.

The core pathophysiology, which is illustrated in figure 48 .3, is a cycle of obstruction and destruction.

It's driven by the sickling of the cells under conditions of stress, dehydration, acidosis or hypoxia.

The text has a powerful analogy for this, visualizing the mechanics of vaso -occlusion.

Yes, imagine the blood vessels as fine tubes.

Normal, biconcave RBCs are flexible, like smooth marbles rolling through easily.

Sickled cells are rigid, crescent -shaped, and adhesive -like tiny hooked screws.

So when you try to push hundreds of screws through a narrow tube, they immediately clump, they adhere to the vessel wall, and they block the flow.

This blockage vaso -occlusion leads to local hypoxia, ischemia, tissue infarction, and eventually cellular death across multiple organs.

And this vaso -occlusion, or VOC, is the root cause of the episodic crises listed in box 48 .2.

The most common is the painful episode, or the VOC itself.

That is the hallmark of the disease,

severe pain caused by ischemia in any part of the body, often the extremities, the abdomen, or the joints.

And in infants, what's the first manifestation we often see?

Frequently, it's dactylitis, a painful swelling of the hands and feet.

But the truly life -threatening crises require immediate identification and intervention.

Like the sequestration crisis.

Clinically, this sounds terrifying.

It's defined by the rapid pooling of blood.

It is an ominous acute event, usually involving the spleen and liver.

This rapid pooling leads to massive decreases in circulating blood volume, which can culminate in hypovolemic shock.

And that requires immediate volume replacement and often blood transfusions.

Absolutely.

Other crises include the aplastic crisis, which is a sudden decrease in production, and acute chest syndrome, or ACS.

Acute chest syndrome is a top cause of death in SCA patients.

What should alert the nurse immediately?

ACS is clinically characterized by a new pulmonary infiltrate on chest X -ray, combined with fever, chest pain or cough,

and a declining oxygen saturation.

It can quickly escalate to respiratory failure.

And we can't forget about cerebrovascular accident, CVA, or stroke.

Right, caused by cerebral vessel blockage.

It can lead to sudden severe neurological deficits.

We're talking paralysis, slurred speech, or intractable headaches.

So management has to be aggressive, focusing on prevention and immediate symptomatic support during a crisis.

Early identification is key.

It is.

It enables preventative measures like prophylactic penicillin.

Prophylactic oral penicillin must start by two months of age for all children under five.

Why is that so critical?

Because repeated splenic damage from sickling leads to what we call functional splenia.

The spleen just doesn't work anymore.

Leaving the child highly vulnerable.

To encapsulated organisms like striptococcus pneumonia.

Routine immunizations must be supplemented with specialized pneumococcal and meningococcal vaccines, plus the annual flu shot.

Crisis management is often summarized in a concise protocol.

Rest, hydration, electrolyte replacement, analgesics, blood replacement, and antibiotics.

Let's drill into the why for electrolyte replacement.

The why is physiological.

Metabolic acidosis actively promotes sickling.

By correcting fluid and electrolyte imbalances, we help reverse that acidotic state, which in turn reduces further sickling.

And what about oxygen?

We use oxygen for comfort, and to keep the O2 sat at or above 95%.

But it often cannot reverse existing blockages in the microcirculation.

The damage is already done in those vessels.

Pain management must be aggressive, which requires educating families and providers against the myths of addiction.

The text is very clear on this.

Opioid dependency is rare in this population, and should never deter appropriate pain relief.

Patient -controlled analgesia, or PCA, is successfully used for severe VOCs.

And there's a crucial physical alert for nurses.

Yes, avoid cold compresses.

Cold causes vasoconstriction and promotes sickling.

Always use heat to the affected area to encourage vasodilation and blood flow.

Let's talk about hydroxyurea, the disease -modifying drug.

Hydroxyurea has transformed management of SCA.

Its mechanism is the induction of fetal hemoglobin, HDBF, which resists sickling.

So by increasing HDBF?

It effectively reduces the frequency of both painful VOCs and the potentially fatal acute chest syndrome, significantly improving quality of life and longevity.

So the nursing priorities really focus on vigilance, hydration, prevention of infection, and recognizing those immediate danger signs.

Yes, specific fluid goals, not just vague instructions, are necessary.

Parents must report any fever of 38 degrees Celsius or higher immediately as infection can trigger a crisis.

And they must know the signs of sequestration.

Rapid abdominal swelling, pallor, shock,

and critically, the signs of a CVA.

A sudden, unrelieved headache, slurred speech, or one -sided weakness.

Immediate action is required for these.

And we can't overlook the immense psychosocial burden.

This is a chronic, painful, and potentially fatal illness that requires lifelong psychological and financial support for the entire family.

It's a huge burden.

Okay, let's move to beta thalassemia, another major disorder of destruction, often called Cooley anemia.

It's a common genetic disorder, highly prevalent in populations originating near the Mediterranean Sea.

The core issue is a deficiency in the rate of production of beta -globin chains in hemoglobin.

And thalassemia major is the severe homozygous form.

What is the fundamental pathophysiological consequence here?

The defective beta chain production leads to unstable hemoglobin, causing the red blood cells to be structurally damaged and then quickly destroyed.

This process is called hemolysis.

Which results in severe, persistent anemia.

Right.

The body attempts to compensate by massively overproducing defective RBCs, which causes bone marrow expansion and even bony deformities.

Critically, because the constant hemolysis and the necessary frequent transfusions, the body accumulates massive amounts of iron.

A condition called hemocytosis.

Exactly.

So management becomes this two -pronged attack, treating the anemia and then treating the iron that results from the treatment.

That's a perfect way to put it.

Transfusions are the foundation of care, given every three to five weeks to maintain HGB levels above 90 grams per liter.

This suppresses that ineffective bone marrow activity.

But those transfusions mandate lifelong chelation therapy to manage the hemocytosis?

They do.

Iron overload is the leading cause of death in thalassemia.

It destroys organs like the heart, causing cardiomyopathy and the pancreas, which leads to diabetes.

So how is that essential chelation therapy administered and why is adherence so difficult?

Well, historically, it involved parenteral deferroximin, which required a continuous subcutaneous infusion over eight to 10 hours, five to seven days a week, often via a pump.

That's incredibly demanding.

Incredibly.

While newer oral agents like deferrescerox have improved quality of life, adherence remains a major challenge due to the intensity and just the sheer duration of the treatment.

So the nursing role here is immense.

Promoting adherence, explaining that the risk of heart disease and diabetes from untreated iron overload is real and cumulative.

And providing vital genetic counseling to the family.

Occasionally, a splenectomy may be necessary if the spleen is enlarged and accelerating RBC destruction.

But that's a trade -off, isn't it?

It is.

It comes with an increased risk of overwhelming life -threatening infection, requiring vigilant prophylactic antibiotics and vaccinations post -surgery.

Our final red cell disorder is a plastic anemia, or AA.

This is straight -up bone marrow failure.

Yes, it's defined by the simultaneous depression of all form blood elements.

We call that pancytopenia.

So you have profound anemia, leukopenia, and thrombocytopenia all at once.

The etiology is often idiopathic, meaning acquired.

But it can be congenital, as seen in fanconi anemia, or secondary to infections, irradiation, or certain medications.

The child is just dangerously vulnerable due to the complete lack of defense systems.

The definitive diagnostic test here is the bone marrow aspiration.

What does the nurse expect the results to show that distinguishes it from leukemia?

In AA, the biopsy shows a conversion from normal red hematopoietic marrow to yellow fatty marrow.

Unlike leukemia, where the marrow is hypercellular but overrun with non -functional cells, AA shows profound hypocelularity.

And the severity is defined by?

By the degree of that cellularity loss and the resulting blood counts.

Treatment focuses strictly on restoring marrow function.

We have two main pathways, immunosuppression and hematopoietic stem cell transplantation, or HSCT.

Right.

Immunosuppression, using antithemocyte globulin, ATG, and cyclosporine, aims to eliminate the presumed autoimmune component that is destroying the marrow.

ATG is a powerful drug, typically given IV over several days.

But HSCT is the goal.

HSCT is the treatment of choice if a matched donor is available.

Outcomes for matched unrelated donor transplants have improved dramatically, often exceeding 75 % survival, making it a viable, potentially curative option.

And the nursing care here aligns with the most critical aspects of leukemia management, right?

Focusing intensely on preventing complications from pancreatopenia.

Yes, and specifically for ATG administration, it often requires a central line.

And the nurse must be vigilant about IV site care, given the risk of extravasation.

More importantly, ATG can cause profound hypersensitivity reactions.

So, meticulous monitoring for fever, chills, and allergic signs during and immediately after infusion is mandatory.

We're shifting now from cell production and destruction to the plumbing defects and hemostasis.

Hemophilia, an X -linked recessive disorder, is the classic example, predominantly affecting males.

Hemophilia A, factor eight deficiency, is the most common form.

The common misconception is that people with hemophilia bleed faster.

They do not, they bleed longer.

Factor eight is essential for the stabilization of the fibrin clot, as figure 48 .4 illustrates.

Without sufficient factor, the clot formation is impaired, leading to prolonged bleeding from minor injuries or even spontaneous internal bleeding.

What are the primary clinical manifestations we see, especially in growing active children?

The primary most damaging site is hemarthrosis that's bleeding into the joint spaces, typically the knees, ankles, and elbows.

And that leads to long -term problems.

Recurrent hemarthrosis causes joint damage, leading to chronic pain and crippling deformities over time.

The early signs can be subtle, just joint stiffness or a tingling sensation before any obvious swelling occurs.

But there are life -threatening bleeds too.

Yes, soft tissue bleeds in the neck or mouth, which risk airway obstruction or intracranial hemorrhage, which remains a major cause of mortality.

Therapeutic management relies almost entirely on factor replacement.

That's right.

We replace the missing factor, factor VIII concentrate, either derived from plasma or, more commonly now, a recombinant product.

And for mild cases.

For mild hemophilia A, the synthetic hormone DDAVP can be used, which temporarily increases plasma factor VIII activity.

However, DDAVP is useless for severe factor VIII deficiency or for hemophilia B.

The standard of care has evolved significantly toward prophylaxis.

Why is primary prophylaxis so important?

Primary prophylaxis, that's the regular infusion of factor concentrate before any joint damage occurs, is critical to prevent the chronic crippling joint disease associated with recurrent bleeds.

And secondary prophylaxis.

That starts after the first joint bleed.

This preventative strategy drastically improves the patient's long -term mobility and quality of life.

Home treatment is heavily encouraged, fostering self -esteem and independence.

Beyond replacement, nurses play a major role in preventing and controlling bleeds.

What are the key safety measures?

First, you have to create a safe environment that still allows for age -appropriate activity.

So encourage non -contact sports like swimming, hiking, or golf.

And in terms of medical procedures.

We must avoid IM injections entirely, substituting the subcutaneous route or venipuncture with prolonged pressure.

And crucially, strictly avoid all platelet -inhibiting drugs like aspirin and NSAIDs.

Acetaminophen is the pain relief substitute.

If a bleed does occur, we use the price acronym.

Let's detail those steps.

Price must be implemented immediately alongside factor replacement.

It's protection of the joint,

rest, ice, to vasoconstrict and reduce swelling, compression, and elevation.

And for joint bleeds specifically.

The joint must be immobilized in the acute phase.

And this is important.

Active range of motion exercises are only instituted after the acute phase has subsided to prevent contractures.

Passive ROM is strictly avoided to prevent further trauma.

And we also have to support the mother, who often carries a lot of guilt about transmitting this X -linked disorder.

A huge part of the nursing role.

Let's contrast hemophilia with immune thrombocytopenia, or ITP, a much more common platelet disorder in children.

ITP is an acquired disorder, often following a viral infection where antibodies target and destroy platelets.

This leads to thrombocytopenia and results in excessive bruising and bleeding.

So it's the most common childhood thrombocytopenia, but the good news is.

The good news is that 80 % of acute cases are self -limited.

They resolve spontaneously within six to 12 months.

Management is primarily supportive, restricting activity when platelet counts are low, often below 50 times 10 to the nine per liter.

What are the primary pharmacological interventions?

We might use corticosteroids to decrease the immune destruction or IVIG.

We also have to note the specific use of anti -deantibody, which is only an option for RH positive children.

How does that work?

It creates a mild temporary anemia, which basically distracts the immune system from destroying the platelets.

And the major nursing alert regarding anti -D?

If anti -D is administered, the child must be observed for a minimum of eight hours with frequent vital signs, watching meticulously for immediate reactions like fever, chills, or headache.

And for all ITP patients.

The activity restriction must be enforced.

No contact sports, no bicycle riding, and absolutely no aspirin or NSAIDs.

Splenectomy is reserved only for chronic cases unresponsive to therapy, and is usually delayed until after age five to minimize infection risk.

Next, Disseminated Intravascular Coagulation, DIC, which is a secondary disorder representing a catastrophic failure of the coagulation system.

DIC is the ultimate paradox in coagulation, as shown in figure 48 .5.

Coagulation pathways are abnormally stimulated, leading to simultaneous diffuse clotting and the rapid consumption of all clotting factors.

So the child is clotting inappropriately everywhere, leading to organ ischemia and thrombosis.

While simultaneously bleeding uncontrollably from every orifice and insertion site, it is a secondary disorder, triggered by massive underlying issues like sepsis, shock, or severe trauma.

The manifestations in box 48 .7 are terrifying.

Patechia, purpura, bleeding from orifices combined with signs of systemic shock.

Management must be swift.

The fundamental management is simple in concept, but difficult in practice.

You have to control the underlying cause.

While that's happening, we replace the consumed components platelets in fresh frozen plasma.

What about heparin?

Heparin may be used in rare non -responsive cases to halt the destructive clotting cycle, but that's a very specialized decision.

Finally, the most common localized bleeding issue, epistaxis or nose bleeding.

Usually caused by trauma or inflammation, but recurrent or severe bleeding warrants evaluation for an underlying systemic disease like hemophilia or leukemia.

The emergency nursing care steps are vital here.

Keep the child calm, sit them up, and lean forward to prevent blood aspiration and apply continuous firm pressure to the soft lower part of the nose for at least 10 minutes.

If it persists past 20 to 30 minutes, medical evaluation is required.

We're moving into neoplastic disorders, starting with leukemia, the most common childhood cancer.

It's a malignant disease of the bone marrow and lymphatic system.

An acute lymphoid leukemia, ALL, is the most common type.

It accounts for about 75 % of cases, with a peak onset between two and five years.

The good news, thanks to aggressive, protocol -driven treatment, is that five -year survival rates for ALL now approach 94%.

Let's dissect the core pathophysiology from figure 48 .6.

It's not a solid tumor, it's a systemic problem of unregulated immature cell proliferation.

The mechanism of injury is twofold, infiltration and competition.

Grunt -restricted proliferation of immature, non -functional WBCs quickly invades the bone marrow.

These immature cells compete aggressively for nutrients and physical space.

Which profoundly suppresses the production of all normal, healthy -formed elements.

Exactly, and this directly explains the three classic consequences you see at presentation.

First, anemia from decreased RBCs causing pallor and fatigue.

Second, infection due to neutropenia, the lack of functional WBCs.

And third, bleeding due to decreased platelets.

Furthermore, the sheer invasion into the bone causes severe pain and pathological fractures.

Invasion into organs like the spleen, liver, and lymph nodes causes visible enlargement.

The initial presentation can be so insidious.

Unexplained fever, persistent fatigue, bruising, and bone or joint pain that's often misdiagnosed.

It is, and prognostic factors are crucial for tailoring the intensity of the treatment protocol.

Key factors include the initial WBC count, the child's age two to nine years is generally most favorable, the specific cell type, and whether there is early CNS involvement.

And we now have ways to prevent that CNS involvement.

Prophylactic intrathecal chemotherapy, which delivers agents directly into the spinal fluid, has drastically reduced the risk of CNS relapse.

Therapeutic management follows four distinct, intensive phases that can last two to three years.

First is induction, which lasts four to five weeks.

This is the high stakes phase.

The goal is complete remissionless than 5 % leukemic cells in the marrow.

This involves profound myelosuppression, making the child maximally vulnerable.

Then what?

Then you have CNS prophylactic therapy, often given at the same time.

Then intensification or consolidation, which are aggressive cycles to eliminate any residual cells.

And finally, maintenance, which is lower dose therapy for two to three years to preserve that remission.

Given the high survival rates now, we have to dedicate attention to the late effects.

These are the burdens of aggressive treatment.

This is a huge growing area of nursing advocacy.

Aggressive chemotherapy and irradiation carry significant lifelong risks.

We worry about second malignancies, particularly brain tumors from cranial irradiation.

And cardiomyopathy.

Yes, we must track for cardiomyopathy caused by anthrocycline agents like doxorubicin, which have cumulative cardiotoxicity that can manifest as silent heart failure decades later.

Okay, for the core nursing care, managing myelosuppression and toxicity.

Priority one is infection prevention due to neutropenia.

Infection prevention is the non -negotiable priority.

This means strict hand hygiene, private rooms, restricting sick visitors, constant surveillance.

The child usually needs an ANC greater than 1 .0 before they can safely return to school.

And the vaccine alert.

Live vaccines, MMR, varicella, are strictly contraindicated during periods of immunosuppression.

They must be deferred.

And revaccination is recommended three to six months after chemotherapy is completed.

Priority two, hemorrhage prevention due to thrombocytopenia.

We must avoid all activities that could cause injury.

This means no rectal temperatures or suppositories, which risk mucosal trauma.

Meticulous gentle mouth care.

Avoid activities like bicycle riding or contact sports.

Platelet transfusions are reserved for active bleeding episodes only.

Let's walk through that high stakes moment for the nurse.

Chemotherapy administration.

We know many agents are vesicans.

What is the immediate detailed action plan if extravasation is suspected?

This is critical as vesicans cause severe tissue damage.

The nurse must ensure the agent is administered through a freely flowing 5E line.

If the child reports pain, stinging or swelling at the site, the infusion must be stopped immediately.

And then what?

Do not flush the line.

Do not flush the line.

You aspirate the remaining drug from the line.

You might instill a specific antidote into the site and then you notify the provider.

And you must observe the patient for a full 30 minutes post -infusion for signs of anaphylaxis, keeping emergency equipment ready.

Let's quickly detail the management of common toxicities for nausea and vomiting.

We aim for prevention.

Serotonin receptor antagonists like Ondansetron are combined with dexamethasone and administered before chemotherapy begins to prevent that anticipatory response.

Mucosal ulceration or stomatitis is highly distressing and painful.

Management focuses on comfort and infection control.

We recommend a bland, moist, soft diet and a soft sponge toothbrush.

Cellene or sodium bicarb mouthwashes help clean the mouth.

And the critical safety warning here.

Do not use viscous lidocaine in young children.

It risks depressing the gag reflex, which can lead to aspiration.

For rectal ulcers, meticulous perianal care, sits, baths and school softeners are necessary.

Seropathy, often caused by agents like Finchristine, affects both the gut and the extremities.

Yes, decreased bowel innervation commonly results in severe constipation, requiring scheduled use of school softeners.

Peripheral neuropathy can cause foot drop, so nurses must implement safety measures for ambulation, maybe a footboard to prevent contractures.

And we need to educate parents on steroid effects.

Very much so.

The temporary moon face appearance, fluid retention and pronounced mood changes, from euphoria to severe irritability.

Let's move to lymphomas.

The third most common pediatric malignancy group.

Hodgkin disease, HD, is distinguished by the presence of Reed -Sternberg cells.

And it tends to originate in the lymphoid system with a predictable metastasis.

HD has an excellent prognosis, with 97 % five -year survival for children in Canada.

Staging uses systems like Ann Arbor -Lugano, and we use B symptoms, unexplained fever, night sweats, weight loss, to indicate advanced disease.

The manifestations are typically painless, firm enlargement of lymph nodes, most commonly cervical or supraclavicular.

Nursing care often involves preparing adolescents for biopsy and discussing key long -term implications.

The high risk of sterility from the combined effects of chemo and irradiation is a major concern for adolescents.

Nurses must proactively counsel them about fertility preservation options, like sperm banking or egg freezing before treatment begins.

And we also monitor for late effects like hypothyroidism.

Yes, a common late effect of neck irradiation.

Non -Hodgkin lymphoma, NHL, is actually more frequent in children than HD and tends to be more aggressive.

NHL is diverse, like Birkitt or lymphoblastic lymphoma, and it's rapidly disseminating.

It's staged using the St.

Jude system.

Management involves aggressive, multi -agent chemotherapy, similar to leukemia protocols.

So the nursing focus remains intensely fixed on managing the adverse effects of that intense chemotherapy.

Exactly, though prognosis is excellent for localized disease.

We're shifting now to immunological deficiencies, beginning with HIV and AIDS.

The Canadian context shows immense success here.

Vertical transmission rates are now below 2 % due to robust screening and antiretroviral therapy aren't used during pregnancy.

It's a true public health success story.

But transmission remains a concern in youth.

Primarily through unsafe sexual activity and IV drug use.

HIV is a retrovirus that attacks and gradually depletes the body's essential CD4T cells, leading to progressive immunodeficiency.

Diagnosis is challenging in infants due to persistent maternal antibodies.

How do we confirm diagnosis in a newborn versus an older child?

Because maternal antibodies can persist up to 18 months, we can't use antibody tests like ELISA.

So in children under 18 months, we rely on the HIV PCR test to detect the actual proviral DNA.

And for children 18 months or older?

The standard antibody tests suffice.

The CDC classification system in table 48 .2 is a key tool for guiding care.

How does the nurse interpret this table?

The system crosses clinical categories from N for asymptomatic to C for severe with immune categories one, two, and three, which are based on CD4 counts.

So a child classified as B3 has moderate symptoms and severe immunosuppression.

And that guides the initiation of prophylaxis.

It does.

Therapeutic management is lifelong RT using combination therapy to suppress viral replication.

And prophylaxis is crucial, especially against pneumocystis carinia pneumonia, or PCP.

And that means?

Prophylactic trimethoprim sulfamethoxazole, TMP SMZ, is mandatory for infants during the first year of life.

And while routine immunizations are given, live vaccines like varicella and MMR are only given if the child is not severely immunocompromised.

Nursing care involves intensive infection control education and psychosocial support.

We have to actively dispel myths surrounding transmission to combat the severe ostracization and stigma families face.

Also, aggressive pain management is required.

We must look for nonverbal signs of pain, like emotional detachment or irritability.

Let's briefly touch on two severe primary immunodeficiency disorders.

First, SCID, historically known as bubble boy disease.

SCID is the catastrophic absence of both humoral and cell -mediated immunity.

The child has essentially no immune system.

Notably, there is a high incidence of SCID among indigenous infants in Canada.

And the only treatment.

The definitive curative treatment is hematopoietic stem cell transplantation, HSCT.

The nursing focus is hypervigilance regarding infection prevention and intensive family support as the prognosis is poor without a matched donor.

And finally, Wiskott -Aldrich syndrome, or WAS.

WAS is an X -length recessive disorder characterized by a classic triad, atopic dermatitis or severe eczema,

thrombocytopenia with small defective platelets, and susceptibility to recurrent infection.

And again, the only cure is HSCT.

That's right.

Nursing care is a balance of controlling bleeding, managing the eczema, and rigorous infection prevention.

Transfusion therapy is a powerful tool, but it carries profound risk.

We have to review the critical safety guidelines as human error resulting in ABO incompatibility remains the leading cause of transfusion death.

The safety guidelines are absolutely non -negotiable.

First, get a baseline set of vitals.

Second, and most critically, confirm the recipient's identity, the donor's blood group, and the type verification with another nurse before administering.

And the infusion itself.

The rate must be slow for the first 15 minutes, and the nurse must remain with the patient, monitoring for immediate reactions.

And what about the setup requirements?

Normal saline is the only acceptable solution to be piggybacked with blood.

No medications, no other solutions, use an appropriate filter.

And critically, a unit of blood must be infused within four hours to prevent bacterial proliferation.

Let's detail the signs and immediate nursing actions for the major reactions from table 48 .3.

A hemolytic reaction, the most severe.

They're rare, but devastating.

Signs include sudden severe headache, fever, chills, pain along the vein, and ominous red or black urine from hemolysis.

Action.

Stop the transfusion immediately.

Maintain a patent IV line with normal saline.

Notify the provider.

Save the blood bag and tubing for recross match.

And monitor for shock and renal failure.

For febrile or allergic reactions.

These are less severe fever, chills, hives.

Action is to stop the transfusion, notify the provider, and administer antihistamines or antipyretics as ordered.

The physician might order it to resume slowly if symptoms are mild.

And circulatory overload, a major concern in our anemic patients.

It results from excessive or rapid volume.

Signs are dyspnea, a dry cough, reels in the lungs, and distended neck veins.

And the action is.

Stop the transfusion.

Place the child in an upright position with their feet dependent to decrease venous return to the heart.

This is why we prefer packed RBCs.

To minimize the volume.

HSCT is the definitive treatment for so many of these conditions.

It is an intensive, high stakes process.

The process starts with intensive, ablative therapy, high dose chemo, and or total body radiation.

To suppress the immune system and destroy the patient's diseased bone marrow.

This is followed by the 5E infusion of harvested stem cells.

The family centered care box emphasizes how severe this decision is.

What makes the preparatory regimen so high risk?

Once the ablative therapy begins, the patient's immune system is functionally destroyed.

There is no rescue procedure.

They are utterly dependent on the engraftment of the donor cells.

The risk is immense.

And success hinges on matching.

The critical challenge is.

HLA matching.

Histocompatibility is crucial to prevent graft versus host disease, GVHD, where the new donor immune cells recognize the recipient's tissues as foreign and attack them.

We hear a lot about umbilical cord blood now.

Umbilical cord blood is an established source because those cells are immunologically naive, offering a lower risk of severe GVHD, even with a partial match.

And nursing care during the three to six weeks of isolation must be rigorous and unrelenting.

It is intensive, supportive care.

Infection prevention is paramount.

Every interaction, every linen change, every meal must be managed with an almost surgical level of vigilance.

Our final technological management tool is a phoresis.

What is its dual function?

A phoresis is the process of selectively removing blood components.

Its functions are twofold.

First, collection, like collecting platelets from donors or harvesting stem cells for a transplant.

And second, it's therapeutic use.

Therapeutically, it's used to remove diseased or toxic components.

For example, removing plasma in hyperviscosity syndromes.

Nursing care focuses on monitoring vitals for circulatory changes and ensuring meticulous identification protocols.

We have journeyed through an enormous chapter covering everything from the single hemoglobin molecule and sickle cell anemia to the vast complexity of HSCT.

If you, the listener, take away three core principles for your practice today, let them be principles of vigilance.

My synthesis would emphasize these actions.

First, master CBC interpretation.

Immediately recognize a shift to the left and know the ANC thresholds for neutropenic precautions.

Second, be acutely vigilant for crisis signs and sickle cell anemia fever, sequestration CVA.

Initiate rapid pain relief.

And remember that cold is contraindicated.

And third, manage the extreme vulnerability of chemotherapy patients by strictly adhering to procedural safety, from meticulous administration of vesicans to knowing why we must never use viscous lidocaine for mucositis in young children.

That is a powerful and concise summary of this complex material.

And as we close, let's consider the long game.

We've seen incredible advancements resulting in high survival rates for these children.

But how does the nurse focused on acute care today pivot to advocate for the holistic health and quality of life of these children years after they are technically cured?

What do you mean?

The challenge is ensuring their lifelong surveillance for late effects, including cardio toxicity, endocrine issues and cognitive deficits to truly maximize their long -term outcome.

That is the definition of advanced pediatric nursing.

A deeply important reminder of continuity of care.

Thank you for joining us on this vital deep dive into hematological and immunological conditions.

We hope you feel thoroughly informed and prepared for the bedside.

We'll see you next time.